This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CORPUS_UTERI_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CORPUS_UTERI_EXALLC for full statistics.
C3_CORPUS_UTERI
endometrial carcinoma: A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.
392423 individuals
Apply sex-specific rule
219462
Check conditions None
219462
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
2026
Check minimum number of events None
2026
Include endpoints None
2026
Remove individuals based on genotype QC
1967
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
List of similar endpoints to Malignant neoplasm of corpus uteri based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 1967 | 1967 | - |
Unadjusted prevalence (%) | 0.52 | 0.93 | - |
Mean age at first event (years) | 64.27 | 64.27 | - |
Not a core endpoint, no data to show.
Not a core endpoint, no data to show.
Index endpoint: C3_CORPUS_UTERI – Malignant neoplasm of corpus uteri
GWS hits:
Not a core endpoint, no data to show.
Endpoint not on priority list, no data to show.